A new CYP3A5 variant, CYP3A5*11, is shown to be defective in nifedipine metabolism in a recombinant cDNA expression systemLEE, Su-Jun; VAN DER HEIDEN, Ilse P; GOLDSTEIN, Joyce A et al.Drug metabolism and disposition. 2007, Vol 35, Num 1, pp 67-71, issn 0090-9556, 5 p.Article

CYP3As variant allele frequencies in Dutch CaucasiansVAN SCHAIK, Ron H. N; VAN DER HEIDEN, Ilse P; VAN DEN ANKER, John N et al.Clinical chemistry (Baltimore, Md.). 2002, Vol 48, Num 10, pp 1668-1671, issn 0009-9147, 4 p.Article

Age and CYP3A5 genotype affect tacrolimus dosing requirements after transplant in pediatric heart recipientsGIJSEN, Violette; MITAL, Seema; VAN SCHAIK, Ron H et al.The Journal of heart and lung transplantation. 2011, Vol 30, Num 12, pp 1352-1359, issn 1053-2498, 8 p.Article

MDR1 gene polymorphisms are associated with neuropsychiatric adverse effects of mefloquineAARNOUDSE, Albert L. H. J; VAN SCHAIK, Ron H. N; DIELEMAN, Jeanne et al.Clinical pharmacology and therapeutics. 2006, Vol 80, Num 4, pp 367-374, issn 0009-9236, 8 p.Article

Propofol pharmacokinetics and pharmacodynamics for depth of sedation in nonventilated infants after major craniofacial surgeryPEETERS, Mariska Y. M; PRINS, Sandra A; KNIBBE, Catherijne A. J et al.Anesthesiology (Philadelphia). 2006, Vol 104, Num 3, pp 466-474, issn 0003-3022, 9 p.Article

Maternal Medication Use, Carriership of the ABCB1 8435C > T Polymorphism and the Risk of a Child With Cleft Lip With or Without Cleft PalateBLIEK, Bart J. B; VAN SCHAIK, Ron H. N; VAN DER HEIDEN, Ilse P et al.American journal of medical genetics. Part A. 2009, Vol 149, Num 10, pp 2088-2092, issn 1552-4825, 5 p.Article

Genetic polymorphisms of the CYP3A4, CTP3A5, and MDR-1 genes and pharmacokinetics of the calcineurin inhibitors cyclosporine and tacrolimusHESSELINK, Dennis A; VAN SCHAIK, Ron H. N; VAN DER HEIDEN, Ilse P et al.Clinical pharmacology and therapeutics. 2003, Vol 74, Num 3, pp 245-254, issn 0009-9236, 10 p.Article

General maternal medication use, folic acid, the MDR1 C3435T polymorphism, and the risk of a child with a congenital heart defectOBERMANN-BORST, Sylvia A; ISAACS, Aaron; YOUNES, Zobia et al.American journal of obstetrics and gynecology. 2011, Vol 204, Num 3, pp 236-238, issn 0002-9378, 3 p.Article

A New Functional CYP3A4 Intron 6 Polymorphism Significantly Affects Tacrolimus Pharmacokinetics in Kidney Transplant RecipientsELENS, Laure; BOUAMAR, Rachida; HESSELINK, Dennis A et al.Clinical chemistry (Baltimore, Md.). 2011, Vol 57, Num 11, pp 1574-1583, issn 0009-9147, 10 p.Article

ABCB1 gene polymorphisms are not associated with treatment outcome in elderly acute myeloid leukemia patientsVAN DER HOLT, Bronno; VAN DEN HEUVEL-EIBRINK, Marry M; VAN SCHAIK, Ron H. N et al.Clinical pharmacology and therapeutics. 2006, Vol 80, Num 5, pp 427-439, issn 0009-9236, 13 p.Article

The interactions of age, genetics, and disease severity on tacrolimus dosing requirements after pediatric kidney and liver transplantationDE WILDT, Saskia N; VAN SCHAIK, Ron H. N; SOLDIN, Offie P et al.European journal of clinical pharmacology. 2011, Vol 67, Num 12, pp 1231-1241, issn 0031-6970, 11 p.Article

Population pharmacokinetics of cyclosporine in kidney and heart transplant recipients and the influence of ethnicity and genetic polymorphisms in the MDR-1, CYP3A4, and CYP3A5 genesHESSELINK, Dennis A; VAN GELDER, Teun; VAN SCHAIK, Ron H. N et al.Clinical pharmacology and therapeutics. 2004, Vol 76, Num 6, pp 545-556, issn 0009-9236, 12 p.Article